The Crescent™ catheter is the first FDA-cleared jugular dual-lumen long-term ECMO catheter, offering:
Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician..
Find more information, including other available configurations, for Crescent™ jugular dual-lumen catheter.